Full-year sales reached $26.8 billion, driven by robust performance across HIV, oncology, and liver disease portfolios. HIV sales grew 8% year-over-year to $19.6 billion in 2024, exceeding ...

Levy’s materials cover the gamut of topics across virology before the epidemic. But once the timeline gets to 1981, most all of his papers and notes are on HIV/AIDS research. “It’s amazing just ...

Operator Good afternoon, everyone, and welcome to Gilead's fourth quarter and full year 2024 earnings conference call. My ...

Without treatment, HIV progression into AIDS has three possible timelines: Typical, in a window that lasts five to 10 years Rapid, within three to five years Long-term non-progression, lasting ...

A recent funding freeze from USAID has left South Africa's vital HIV and TB treatment programmes in jeopardy. As experts warn ...

Gilead Sciences, Inc. ( NASDAQ: GILD) Q4 2024 Earnings Conference Call February 11, 2025 4:30 PM ET Jacquie Ross - SVP, Treasury & IR Daniel O'Day - Chairman, CEO Johanna Mercier - Chief Commercial ...

Trump signed his first anti-trans executive order within hours of taking office and has only continued the onslaught. The ...

Two former CEOs were recently convicted for their roles in a scheme to lie to investors in a publicly traded biotechnology ...

IndyGo is hosting a series of events around Indianapolis to answer questions about the Blue Line, the city's next rapid bus ...

A federal judge said Friday he is putting at least a short-term stop to President Trump’s plans to place thousands of ...

EGRIFTA SV® is distributed in the United States only.

A rapid series of agreements between US companies and Tesla CEO Elon Musk's businesses reflect optimism regarding his ...